PREVAIL THERAPEUTICS INC - COM (PRVL) Institutional Ownership

CUSIP: 74140Y101

13F Institutional Holders and Ownership History from Q2 2019 to Q2 2021

Type / Class
Equity / COM
Symbol
PRVL
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 74140Y101?
CUSIP 74140Y101 identifies PRVL - PREVAIL THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of PREVAIL THERAPEUTICS INC - COM (PRVL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q2 0 $0 -$2,833,000 0
2021 Q1 0 $0 -$643,973,457 0
2020 Q4 28,045,096 $646,997,825 +$34,388,927 $23.07 89
2020 Q3 29,720,441 $302,538,838 +$7,659,162 $10.18 74
2020 Q2 28,255,298 $421,003,288 +$7,892,147 $14.90 65
2020 Q1 27,819,755 $339,118,245 +$6,890,459 $12.19 57
2019 Q4 26,958,260 $426,750,661 +$10,276,178 $15.83 44
2019 Q3 26,674,833 $327,561,519 +$1,829,740 $12.28 42
2019 Q2 26,421,832 $348,854,000 +$348,854,000 $13.20 38